NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
NanoViricides, Inc.

BRIEF

published on 10/22/2024 at 12:35, 12 days ago

Le président de NanoViricides fera une présentation à la conférence PODD

NanoViricides NV-387 Administration De Médicaments Conférence PODD Traitements Antiviraux
BRIEF

published on 10/22/2024 at 12:35, 12 days ago

NanoViricides President to Present at PODD Conference

NanoViricides NV-387 Drug Delivery PODD Conference Antiviral Treatments
PRESS RELEASE

published on 10/22/2024 at 12:30, 12 days ago

NanoViricides President Dr. Diwan to Present at the PODD Conference
NanoViricides announces President Dr. Anil R. Diwan to speak at PODD Conference about revolutionary antiviral nanomedicines. Conference focuses on drug delivery partnerships and trends

NanoViricides Drug Delivery Antiviral Nanomedicines PODD Conference Anil R. Diwan
BRIEF

published on 10/15/2024 at 12:35, 19 days ago

Une technologie antivirale innovante évoquée dans le récent podcast NanoViricides

NanoViricides NV-387 Traitement Antiviral Essais De Phase II Technologie De La Nanomédecine
BRIEF

published on 10/15/2024 at 12:35, 19 days ago

Innovative Antiviral Technology Discussed in Recent NanoViricides Podcast

NanoViricides NV-387 Antiviral Treatment Phase II Trials Nanomedicine Technology
PRESS RELEASE

published on 10/15/2024 at 12:30, 19 days ago

NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
NanoViricides, Inc. announces interview with Dr. Diwan discussing revolutionary broad-spectrum antiviral clinical drug candidate NV-387 and innovative nanoviricide technology platform

NV-387 Clinical Trials NanoViricides Inc. Antiviral NanoViricides Technology
BRIEF

published on 10/08/2024 at 12:35, 26 days ago

NanoViricides participera au Sommet AMR 2024 sur les technologies pharmaceutiques innovantes

Essais Cliniques Résistance Aux Antimicrobiens Sommet AMR 2024 Technologie Des Nanoviricides Médicament NV-387
BRIEF

published on 10/08/2024 at 12:35, 26 days ago

NanoViricides to Address AMR Summit 2024 on Innovative Drug Technologies

Antimicrobial Resistance Clinical Trials AMR Summit 2024 NanoViricides Technology NV-387 Drug
PRESS RELEASE

published on 10/08/2024 at 12:30, 26 days ago

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow
Dr. Diwan to discuss NanoViricides' pathogen-directed attack technology combating AMR at the Global AMR Summit, highlighting the 'shape-shifting' nanoviricide platform

NanoViricides Antiviral AMR Nanomedicines Pathogen-directed Therapy
BRIEF

published on 09/30/2024 at 12:35, 1 month 3 days ago

NanoViricides publie ses résultats financiers annuels et fait progresser le NV-387 vers les essais de phase II

NanoViricides NV-387 Rapport Financier Médicament Antiviral Essais De Phase II

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 19 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 49 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 20 hours 54 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 34 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE